Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 08:27 am Sale | 2026-06-30 | 13G | MBX BIOSCIENCES INC MBX | Deep Track Capital, LP | 1,732,569 3.640% | -456,023 (-20.84%) | Filing History |
| 2026-08-10 5:35 pm Purchase | 2026-08-06 | 13D | MBX BIOSCIENCES INC MBX | Frazier Life Sciences Public Fund, L.P. | 5,243,421 11.700% | 19,326 (+0.37%) | Filing History |
| 2026-08-10 4:44 pm Sale | 2026-08-06 | 13D | MBX BIOSCIENCES INC MBX | ORBIMED ADVISORS LLC | 3,074,853 6.400% | -563,034 (-15.48%) | Filing History |
| 2026-07-29 3:19 pm Purchase | 2026-06-30 | 13G | MBX BIOSCIENCES INC MBX | BlackRock Inc. BLK | 2,628,181 5.500% | 340,684 (+14.89%) | Filing History |
| 2026-07-08 12:59 pm Purchase | 2026-06-30 | 13G | MBX BIOSCIENCES INC MBX | Wellington Management Group LLP | 4,977,523 10.500% | 1,627,562 (+48.58%) | Filing History |
| 2026-07-08 10:11 am Purchase | 2026-06-30 | 13G | MBX BIOSCIENCES INC MBX | FMR LLC | 5,322,885 11.200% | 2,386,201 (+81.25%) | Filing History |
| 2026-06-24 4:05 pm Purchase | 2026-06-16 | 13G | MBX BIOSCIENCES INC MBX | Paradigm BioCapital Advisors LP | 2,493,015 5.200% | 2,493,015 (New Position) | Filing History |
| 2026-05-06 11:30 am Purchase | 2026-03-31 | 13G | MBX BIOSCIENCES INC MBX | FMR LLC | 2,936,684 6.200% | 2,936,684 (New Position) | Filing History |
| 2026-04-27 4:12 pm Purchase | 2026-03-31 | 13G | MBX BIOSCIENCES INC MBX | BlackRock Inc. BLK | 2,287,497 4.800% | 16,336 (+0.72%) | Filing History |
| 2026-02-11 6:42 pm Sale | 2026-02-05 | 13D | MBX BIOSCIENCES INC MBX | ORBIMED ADVISORS LLC | 3,637,887 7.700% | -365,000 (-9.12%) | Filing History |
| 2026-02-10 11:21 am Sale | 2025-12-31 | 13G | MBX BIOSCIENCES INC MBX | Wellington Management Group LLP | 3,349,961 7.500% | -1,473,375 (-30.55%) | Filing History |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | MBX BIOSCIENCES INC MBX | BlackRock Inc. BLK | 2,271,161 5.100% | 2,271,161 (New Position) | Filing History |
| 2025-11-14 4:05 pm Purchase | 2025-09-30 | 13G | MBX BIOSCIENCES INC MBX | Hawryluk P. Kent | 1,995,759 4.300% | 85,127 (+4.46%) | Filing History |
| 2025-11-12 6:44 pm Purchase | 2025-09-30 | 13G | MBX BIOSCIENCES INC MBX | Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. | 2,017,394 4.500% | 227,272 (+12.70%) | Filing History |
| 2025-11-10 5:08 pm Purchase | 2025-11-06 | 13D | MBX BIOSCIENCES INC MBX | New Enterprise Associates 17, L.P. | 3,619,474 8.100% | 4,988 (+0.14%) | Filing History |
| 2025-10-06 12:22 pm Purchase | 2025-09-30 | 13G | MBX BIOSCIENCES INC MBX | Wellington Management Group LLP | 4,823,336 10.800% | 2,556,708 (+112.80%) | Filing History |
| 2025-09-30 7:06 pm Purchase | 2025-09-26 | 13D | MBX BIOSCIENCES INC MBX | ORBIMED ADVISORS LLC | 4,002,887 9.000% | 190,672 (+5.00%) | Filing History |
| 2025-09-30 6:15 pm Purchase | 2025-09-26 | 13D | MBX BIOSCIENCES INC MBX | Norwest Venture Partners XVI, LP | 2,140,989 4.800% | 4,654 (+0.22%) | Filing History |
| 2025-09-30 5:01 pm Purchase | 2025-09-26 | 13D | MBX BIOSCIENCES INC MBX | Frazier Life Sciences Public Fund, L.P. | 5,224,095 11.700% | 666,998 (+14.64%) | Filing History |
| 2025-08-20 5:23 pm Sale | 2025-08-18 | 13D | MBX BIOSCIENCES INC MBX | Frazier Life Sciences Public Fund, L.P. | 4,557,097 13.600% | -1,428,250 (-23.86%) | Filing History |